Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
KR 1020190021339-A2019-03-05
ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
RAMOT AT TEL-AVIV UNIVERSITY LTD.
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
Family of 4
Grouped by a shared priority claim, US 62/355898.
- KR 1020190021339-A2019-03-05
- JP 2019525744-A2019-09-12
- JP 2022184996-A2022-12-13
- JP 2024112982-A2024-08-21
-
WO 2019048660-A12019-03-14
MIC-1 AND GLP-1 FOR USE IN THE TREATMENT OF OBESITY
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019048660-A12019-03-14
- JP 2020533302-A2020-11-19
- US 11260108-B22022-03-01
-
US 10232020-B22019-03-19
Incretin-insulin conjugates
Indiana University Research and Technology Corporation
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10239914-B22019-03-26
In-situ solvent recycling process for solid phase peptide synthesis at elevated temperatures
CEM Corporation
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10239914-B22019-03-26
- EP 3507299-A12019-07-10
-
WO 2019060653-A12019-03-28
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND USES THEREOF
REGENERON PHARMA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10246503-B22019-04-02
Method of improving the pharmacokinetic profile of a therapeutic polypeptide and the use thereof
BEIJING ANXINHUAIDE BIOTECH. CO., LTD.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10253103-B22019-04-09
Antibody specifically binding to GLP-1R and fusion protein thereof with GLP-1
Gmaz Biopharm LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 3463424-A12019-04-10
GLUCAGON-LIKE PEPTIDE-1-T3 CONJUGATES
INDIANA UNIV RESEARCH & TECHNOLOGY CORPORATION
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 3463429-A12019-04-10
INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES
MERCK SHARP & DOHME
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3463429-A12019-04-10
- US 10953076-B22021-03-23
-
JP 2019510014-A2019-04-11
GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY
MedImmune LIMITED,Lutz JERMUTUS,Philip Duncan AMBERY,Maria A BEDNAREK, Marcella PETRONE
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019072963-A12019-04-18
COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS
UNIV COPENHAGEN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10294303-B22019-05-21
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC.
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10294303-B22019-05-21
- US 11046774-B22021-06-29
-
US 10308700-B22019-06-04
GLP-1 derivatives
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2019514949-A2019-06-06
ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
PhaseBio Pharmaceuticals Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019106193-A12019-06-06
PEPTIDE HORMONE WITH ONE OR MORE O-GLYCANS
UNIV COPENHAGEN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019110981-A12019-06-13
GLUCAGON-LIKE PEPTIDES
IMPERIAL INNOVATIONS LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2019516686-A2019-06-20
GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
Ionis Pharmaceuticals Inc,AstraZeneca AB
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2019519478-A2019-07-11
PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS
Ureka Sarl,Robert H Zimmer
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2019520336-A2019-07-18
AQUEOUSLY SOLUBLE & CHEMICALLY STABLE GLUCAGON AGONISTS
Indiana University Research and Technology Corp,Richard DiMarchi, John Mayer,Piort Mroz,Vasily Gelfanov
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019143767-A12019-07-25
METHODS FOR TREATING DIABETES, HEPATITIS, AND/OR INFLAMMATORY LIVER DISEASE
UNIV CONNECTICUT
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019143767-A12019-07-25
- EP 4596042-A22025-08-06
-
KR 1020190088916-A2019-07-29
N-TERMINAL FUSION PARTNER FOR PREPARING RECOMBINANT POLYPEPTIDE AND METHOD OF PREPARING RECOMBINANT POLYPEPTIDE USING THE SAME
PEPGENE INC
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020190088916-A2019-07-29
- JP 2021511785-A2021-05-13
-
US 10370697-B22019-08-06
Propeptide-luciferase fusion proteins and methods of use thereof
THE BROAD INSTITUE, INC., THE GENERAL HOSPITAL CORPORATION and INSTITUTO CARLOS SLIM DE LA SALUD, A.C.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
-
WO 2019149880-A12019-08-08
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID AND A LUBRICANT
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019149880-A12019-08-08
- JP 2020529467-A2020-10-08
- JP 2021105014-A2021-07-26
- JP 2024102371-A2024-07-30
-
KR 1020190098689-A2019-08-22
METHOD OF PREPARING GLUCAGON LIKE PEPTIDE-1 OR ANALOGUES USING FUSION POLYPEPTIDE
PEPGENE INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10407469-B22019-09-10
Programmable polypeptide and nucleic acid nanoparticles
Northwestern University
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10429378-B22019-10-01
Methods of differentiating preadipocytes and uses thereof
Board Of Supervisors Of Louisiana State University
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
-
WO 2019193204-A12019-10-10
PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS
CYPRUMED GMBH
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019193204-A12019-10-10
- JP 2021520391-A2021-08-19
-
WO 2019193576-A12019-10-10
NOVEL GLP-1 ANALOGUES
SUN PHARMACEUTICAL IND LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2019530659-A2019-10-24
IN-SITU SOLVENT RECYCLING PROCESS FOR SOLID PHASE PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES
CEM CORPORATION,Jonathan Collins
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019211451-A12019-11-07
GIP DERIVATIVES AND USES THEREOF
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%Family of 6
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019211451-A12019-11-07
- US 10604555-B22020-03-31
- JP 2020125311-A2020-08-20
- JP 2020528925-A2020-10-01
- KR 1020210005700-A2021-01-14
- US 11633459-B22023-04-25
-
EP 3568149-A12019-11-20
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS, HEPATIC FIBROSIS, AND HEPATIC CIRRHOSIS COMPRISING FUSION PROTEINS
YUHAN CORP
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by a shared priority claim, KR 10-2016-0149866.
- EP 3568149-A12019-11-20
- JP 2020502053-A2020-01-23
- JP 2025114622-A2025-08-05
-
US 10508131-B22019-12-17
Cysteine analogs of exendin-4
Bolder Biotechnology, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2019243502-A12019-12-26
NOVEL COMPOUNDS FOR TREATMENT OF OBESITY
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019243502-A12019-12-26
- JP 2021528437-A2021-10-21
-
JP 2020500890-A2020-01-16
GLP-1/GLP-2 DUAL AGONISTS
ZEALAND PHARMA A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 3596130-A12020-01-22
DUAL-TARGET FUSION PROTEINS COMPRISING THE FC PORTION OF AN IMMUNOGLOBULIN
SUNSHINE LAKE PHARMA CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2020028907-A12020-02-06
COMPOSITIONS AND METHODS FOR IMPROVING THE BIOAVAILABILITY OF GLP1 AND ANALOGUES THEREOF
UNIV BROWN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2020028909-A12020-02-06
ORAL FORMULATIONS WITH INCREASED UPTAKE
UNIV BROWN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2020504713-A2020-02-13
Treatment of Neurological Diseases
Lancaster University Business Enterprises Limited,Christian Holscher
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2020506900-A2020-03-05
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)
AMGEN INC
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/447332.
- JP 2020506900-A2020-03-05
- JP 2022184880-A2022-12-13
- JP 2025011265-A2025-01-23
-
WO 2020043864-A12020-03-05
METHOD OF PREDICTING STAGE OF ULCERATIVE COLITIS
UNIV I TROMSOE NORGES ARKTISKE UNIV
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
-
WO 2020053815-A12020-03-19
RELEASABLE GLP-1 CONJUGATES
QUIAPEG PHARMACEUTICALS AB
Query Match 100.0%Identity 100.0%Family of 6
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020053815-A12020-03-19
- KR 1020210057130-A2021-05-20
- JP 2021535920-A2021-12-23
- US 11357828-B22022-06-14
- US 11957735-B22024-04-16
- JP 2025023928-A2025-02-19
-
WO 2020054287-A2020-03-19
Method for purifying peptide using sulfonic acid compound
NAGASE AND CO LTD
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020054287-A2020-03-19
- JP 2020045327-A2020-03-26
- JP 2020045336-A2020-03-26
-
JP 2020509761-A2020-04-02
Dual-target fusion proteins comprising the Fc portion of an immunoglobulin
SUNSHINE LAKE PHARMA CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2020512295-A2020-04-23
Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Compositions
Arecor Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020200047706-A2020-05-07
GPCR BINDING PROTEINS AND SYNTHESIS THEREOF
TWIST BIOSCIENCE CORPORATION
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 4
Grouped by a shared priority claim, US 62/556863.
- KR 1020200047706-A2020-05-07
- JP 2020536504-A2020-12-17
- US 11407837-B22022-08-09
- JP 2023153821-A2023-10-18
-
WO 2020091068-A2020-05-07
Fusion protein
Ajinomoto Co Inc,XL-protein GmbH
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, JP 2018-207134.
- WO 2020091068-A2020-05-07
- JP 2022013959-A2022-01-19
-
KR 1020200054303-A2020-05-19
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND USES THEREOF
REGENERON PHARMACEUTICALS, INC
Query Match 100.0%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200054303-A2020-05-19
- JP 2020534016-A2020-11-26
- US 11779633-B22023-10-10
- US 12090193-B22024-09-17
- JP 2024178255-A2024-12-24
-
US 10669323-B22020-06-02
Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins
NOVARTIS AG
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2020115113-A12020-06-11
DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE
KOEBENHAVNS UNIV
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 10683334-B22020-06-16
Aqueously soluble and chemically stable glucagon peptides
Indiana University Research and Technology Corporation
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.